Sunshine Biopharma (SBFM) Consolidated Net Income (2011 - 2026)
Sunshine Biopharma's (SBFM) quarterly Consolidated Net Income came in at -$1.2 million in Q1 2026, down 5.43% YoY from -$1.3 million in Q1 2025, and up 42.52% on a QoQ basis from -$2.2 million in Q4 2025.
Sunshine Biopharma (SBFM) Consolidated Net Income (2011 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 14 years of Consolidated Net Income data on file, last reported at -$1.2 million in Q1 2026.
- Quarterly Consolidated Net Income fell 5.43% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.1 million (down 2.69% YoY) and the FY2025 annual result came in at -$6.0 million, down 8.7% from the prior year.
- Consolidated Net Income grew to -$1.2 million in Q1 2026, from -$2.2 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of -$538872.0 in Q2 2022 to a low of -$23.5 million in Q4 2022.
- A 5-year average of -$2.6 million and a median of -$1.2 million in 2022 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2022 — Consolidated Net Income tumbled 3624.47% — and 2023, when it jumped 94.85%.
- Tracing SBFM's Consolidated Net Income over 5 years: stood at -$23.5 million in 2022, then jumped by 94.85% to -$1.2 million in 2023, then slumped by 109.77% to -$2.5 million in 2024, then gained by 14.89% to -$2.2 million in 2025, then surged by 42.52% to -$1.2 million in 2026.
- The last three Consolidated Net Income figures came in at -$1.2 million (Q1 2026), -$2.2 million (Q4 2025), and -$883820.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | -1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.56 Mn |
| Mar 31, 2026 | -1.24 Mn |
| Dec 31, 2025 | -2.16 Mn |
| Sep 30, 2025 | -883,820.00 |
| Jun 30, 2025 | -1.77 Mn |
| Mar 31, 2025 | -1.18 Mn |
| Dec 31, 2024 | -2.54 Mn |
| Sep 30, 2024 | -1.20 Mn |
| Jun 30, 2024 | -983,796.00 |
| Mar 31, 2024 | -1.28 Mn |
| Dec 31, 2023 | -1.21 Mn |
| Sep 30, 2023 | -663,116.00 |
| Jun 30, 2023 | -902,108.00 |
| Mar 31, 2023 | -1.70 Mn |
| Dec 31, 2022 | -23.51 Mn |
| Sep 30, 2022 | -1.46 Mn |
| Jun 30, 2022 | -538,872.00 |
| Mar 31, 2022 | -1.24 Mn |
| Dec 31, 2021 | 667,116.00 |
| Sep 30, 2021 | -4.04 Mn |